LICENCE AGREEMENTLicence Agreement • March 10th, 2021 • Achilles Therapeutics PLC • Biological products, (no disgnostic substances) • England
Contract Type FiledMarch 10th, 2021 Company Industry Jurisdictionthe course of and ongoing performance of the TRACERx Study in other fields as specified in this Agreement, as well as a right to negotiate for a licence over Founders IP which will arise after the Effective Date for a defined period, in each case upon the terms of this Agreement, and CRT wishes to grant such rights to AchillesTx and does so with the consent and support of UCL, UCLB, CRICK, CS, KP and SQ.
LICENCE AGREEMENTLicence Agreement • March 1st, 2021 • Achilles Therapeutics PLC • Biological products, (no disgnostic substances) • England
Contract Type FiledMarch 1st, 2021 Company Industry Jurisdictionthe course of and ongoing performance of the TRACERx Study in other fields as specified in this Agreement, as well as a right to negotiate for a licence over Founders IP which will arise after the Effective Date for a defined period, in each case upon the terms of this Agreement, and CRT wishes to grant such rights to AchillesTx and does so with the consent and support of UCL, UCLB, CRICK, CS, KP and SQ.
LICENCE AGREEMENTLicence Agreement • February 2nd, 2021 • Achilles Therapeutics LTD • Biological products, (no disgnostic substances) • England
Contract Type FiledFebruary 2nd, 2021 Company Industry Jurisdictionthe course of and ongoing performance of the TRACERx Study in other fields as specified in this Agreement, as well as a right to negotiate for a licence over Founders IP which will arise after the Effective Date for a defined period, in each case upon the terms of this Agreement, and CRT wishes to grant such rights to AchillesTx and does so with the consent and support of UCL, UCLB, CRICK, CS, KP and SQ.